BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25127230)

  • 1. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH.
    Sanna D; Ugone V; Lubinu G; Micera G; Garribba E
    J Inorg Biochem; 2014 Nov; 140():173-84. PubMed ID: 25127230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and biotransformation in the plasma and red blood cells of V(IV)O(2+) complexes formed by ceftriaxone.
    Sanna D; Fabbri D; Serra M; Buglyó P; Bíró L; Ugone V; Micera G; Garribba E
    J Inorg Biochem; 2015 Jun; 147():71-84. PubMed ID: 25601642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding Surface Interaction of V
    Sciortino G; Sanna D; Ugone V; Lledós A; Maréchal JD; Garribba E
    Inorg Chem; 2018 Apr; 57(8):4456-4469. PubMed ID: 29613772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies.
    Sanna D; Ugone V; Pisano L; Serra M; Micera G; Garribba E
    J Inorg Biochem; 2015 Dec; 153():167-177. PubMed ID: 26281973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V(IV)O versus V(IV) complex formation by tridentate (O, N(arom), O) ligands: prediction of geometry, EPR 51V hyperfine coupling constants, and UV-Vis spectra.
    Pisano L; Várnagy K; Timári S; Hegetschweiler K; Micera G; Garribba E
    Inorg Chem; 2013 May; 52(9):5260-72. PubMed ID: 23581472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex formation in aqueous solution and in the solid state of the potent insulin-enhancing V(IV)O2+ compounds formed by picolinate and quinolinate derivatives.
    Lodyga-Chruscinska E; Micera G; Garribba E
    Inorg Chem; 2011 Feb; 50(3):883-99. PubMed ID: 21226475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The equilibrium between the octahedral and square pyramidal form and the influence of an axial ligand on the molecular properties of V(IV)O complexes: a spectroscopic and DFT study.
    Gorelsky S; Micera G; Garribba E
    Chemistry; 2010 Jul; 16(27):8167-80. PubMed ID: 20533466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of new non-oxido vanadium(IV) species in aqueous solution and in the solid state by tridentate (O, N, O) ligands and rationalization of their EPR behavior.
    Sanna D; Várnagy K; Lihi N; Micera G; Garribba E
    Inorg Chem; 2013 Jul; 52(14):8202-13. PubMed ID: 23819442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of vanadium(IV) complexes with cis-inositol in aqueous solution and in the solid-state.
    Morgenstern B; Kutzky B; Neis C; Stucky S; Hegetschweiler K; Garribba E; Micera G
    Inorg Chem; 2007 May; 46(10):3903-15. PubMed ID: 17419616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N,N'-ethylenebis(pyridoxylideneiminato) and N,N'-ethylenebis(pyridoxylaminato): synthesis, characterization, potentiometric, spectroscopic, and DFT studies of their vanadium(IV) and vanadium(V) complexes.
    Correia I; Costa Pessoa J; Duarte MT; Henriques RT; Piedade MF; Veiros LF; Jakusch T; Kiss T; Dörnyei A; Castro MM; Geraldes CF; Avecilla F
    Chemistry; 2004 May; 10(9):2301-17. PubMed ID: 15112220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V
    Sanna D; Ugone V; Sciortino G; Buglyó P; Bihari Z; Parajdi-Losonczi PL; Garribba E
    Dalton Trans; 2018 Feb; 47(7):2164-2182. PubMed ID: 29327005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VO2+ complexation by bioligands showing keto-enol tautomerism: a potentiometric, spectroscopic, and computational study.
    Sanna D; Varnágy K; Timári S; Micera G; Garribba E
    Inorg Chem; 2011 Oct; 50(20):10328-41. PubMed ID: 21902189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 3. Antioxidant properties and radical production capability.
    Sanna D; Ugone V; Fadda A; Micera G; Garribba E
    J Inorg Biochem; 2016 Aug; 161():18-26. PubMed ID: 27184413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-chelated species and biological implications.
    Lodyga-Chruscinska E; Sanna D; Garribba E; Micera G
    Dalton Trans; 2008 Sep; (36):4903-16. PubMed ID: 18766223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the cytotoxic, antimetastatic and albumin binding properties of the oxidovanadium(IV) chrysin complex. Structural elucidation by computational methodologies.
    Naso LG; Martínez Medina JJ; Okulik NB; Ferrer EG; Williams PAM
    Chem Biol Interact; 2022 Jan; 351():109750. PubMed ID: 34813780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex formation of vanadium(IV) with 1,3,5-triamino-1,3,5-trideoxy-cis-inositol and related ligands.
    Morgenstern B; Steinhauser S; Hegetschweiler K; Garribba E; Micera G; Sanna D; Nagy L
    Inorg Chem; 2004 May; 43(10):3116-26. PubMed ID: 15132617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation in aqueous solution of a non-oxido V(IV) complex with VN6 coordination. Potentiometric, ESI-MS, spectroscopic and computational characterization.
    Lodyga-Chruscinska E; Szebesczyk A; Sanna D; Hegetschweiler K; Micera G; Garribba E
    Dalton Trans; 2013 Oct; 42(37):13404-16. PubMed ID: 23893076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity.
    Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D
    J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of antidiabetic vanadium compounds with hemoglobin and red blood cells and their distribution between plasma and erythrocytes.
    Sanna D; Serra M; Micera G; Garribba E
    Inorg Chem; 2014 Feb; 53(3):1449-64. PubMed ID: 24437949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of oxidovanadium(IV) by organic radicals.
    Kundu S; Maity S; Maity AN; Ke SC; Ghosh P
    Dalton Trans; 2013 Apr; 42(13):4586-601. PubMed ID: 23353872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.